World Health Organization Raises Alert Over Severe Scarcity of Weight-Loss Injections

Under 10% of people eligible to benefit from GLP-1 drugs like Wegovy can access them, caution the World Health Organization as it releases its first guidance on the medications.

Given in excess of 1,000,000,000 individuals worldwide currently obese, it is urging broader and more equitable access to GLP-1 medication.

Based on estimates, more than two billion are projected to be living with obesity by 2030 unless action is taken.

"Our latest guidelines affirms that obesity is a long-term condition that can be managed with comprehensive and ongoing treatment," stated the agency's head Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are key hurdles to universal availability to the treatments that can assist patients in reducing significant body mass, explains the organization.

Skinny Jab Supply Crisis

Even in the present most favorable outlook, the supply of GLP-1 therapies would only suffice for approximately 100 million people – under 10% of the global need, as stated by the WHO.

The guideline calls on nations and manufacturers to increase availability, via strategies like voluntary licensing.

The intellectual property rights on a key compound – the primary ingredient of a leading brand – is scheduled to end in a number of nations in 2026.

How Weight-Loss Jabs Operate

These medications replicate a biological compound to reduce digestion speed, suppress the appetite and boost feelings of fullness so individuals reduce food intake.

Individuals usually see weight reduction in the initial weeks of beginning the weekly injections.

Evidence points to people may regain a significant portion a year later of stopping the drug, as their usual appetite come back.

Being above a healthy weight increases your chance for developing diseases, including type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity concerns people in countries worldwide and was responsible for 3.7 million deaths worldwide in 2024, per the health agency.